Company profile
Helix BioMedix, Inc.
OTC: HXBM · Healthcare · Biotechnology
#888 of 1,418 Healthcare companies by revenue43rd-percentile growth
EA Score
56CFH 62DQ —GM 45SS 45
v0.1 · 45/100 weight · provisional
↑ balance-sheet leverage, listing tenure · ↓ 3-yr revenue growth, workforce scale
Methodology →Revenue TTM
$807.2k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$551.5k
Employees
8
as of 2026-08-02
Market cap
$229.2k
as of 2026-08-02
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$807.2k$807.2k2025
Net income-$551.5k-$551.5k2025
Operating income-$595.8k-$595.8k2025
Total assets$1.7M$1.7M2025
Liabilities$137.6k$137.6k2025
Equity$1.5M$1.5M2025
Revenue trend
FY2010 – FY2025 · USD
FY10
FY11
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Helix BioMedix, Inc.’s revenue?
Helix BioMedix, Inc. booked $807.2k in FY2025 revenue, growing 0.4% year over year — about the middle of the pack among Healthcare companies we track, at a -68.3% net margin.
Peers · Healthcare
Catheter Precision, Inc.39DOnconetix, Inc.25DHyperion DeFi, Inc.35DImageneBio Inc48DBioCorRx Inc.44DSeres Therapeutics, Inc.52DNeighbors
King →Key facts
CEORobin L. Carmichael
SectorHealthcare
IndustryBiotechnology
HeadquartersBothell, WA
ExchangeOTC: HXBM
Employees8
IPO date1999-03-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.